| Model Number |
453926 |
| Medical Device Problem Code |
Failure to Advance (2524)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/03/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Combination product: yes.Neither the affected device nor the angiographic material was returned.Therefore, no technical investigation on the subject could be performed.The production documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for the reported event.Review of the production documentation confirmed that the device was manufactured according to specifications and passed all in-process and final inspections.Based on the conducted investigations, no material or manufacturing related root cause could be determined.Considering the physicians complaint event description, it seems likely that the root cause for the complaint event is related to the patient's anatomy (i.E., severely calcified target lesion).
|
| |
|
Event or Problem Description
|
|
The orsiro mission drug-eluting stent system was selected for treatment of a severely calcified lesion in a moderately tortuous segment of the proximal om.It is unknown if a pre-dilation of the lesion was performed.The affected device was introduced into the patient's body but could not cross the lesion.It was noted by the physician, that "only a 0.014" guide wire was able to cross the lesion".
|
| |
|
Search Alerts/Recalls
|